Organization Overview
Historical Acquisition Tree
Key: SmithKline Beckman (8) Acquired (4)
Key: SmithKline Beckman (0) Acquired (64)
adapalene (differin) (4 trials)
aflibercept (zaltrap) (3 trials)
alcaftadine (Lastacaft) (6 trials)
benzoyl peroxide (clearasil) (2 trials)
bevacizumab (avastin) (8 trials)
bimatoprost (lumigan) (71 trials)
brimonidine (alphagan) (35 trials)
brinzolamide (azopt) (2 trials)
carboxymethyl cellulose (3 trials)
ceftaroline fosamil (teflaro) (1 trial)
cyclosporine (sandimmune) (17 trials)
dalbavancin (dalvance) (14 trials)
deoxycholic acid (kybella) (5 trials)
dorzolamide (trusopt) (4 trials)
duloxetine (Cymbalta) (1 trial)
eluxadoline (viberzi) (5 trials)
gatifloxacin (Zymar) (7 trials)
ketorolac (acuvail) (9 trials)
levomilnacipran (fetzima) (4 trials)
linaclotide (linzess) (10 trials)
metronidazole (flagyl) (2 trials)
minocycline (minocin) (1 trial)
moxifloxacin (avelox) (4 trials)
naphazoline (visine) (1 trial)
nepafenac (nevanac) (4 trials)
olopatadine (patanol) (4 trials)
omega-3 fatty acids (Omacor) (1 trial)
onabotulinumtoxinA (Botox) (37 trials)
oxybutynin (ditropan) (2 trials)
oxymetazoline (ocuclear) (4 trials)
pheniramine (Tripoton) (1 trial)
ranibizumab (lucentis) (18 trials)
rimabotulinumtoxinB (Myobloc) (129 trials)
tafluprost (zioptan) (1 trial)
tazarotene (tazorac) (5 trials)
testosterone (delatestryl) (2 trials)
timolol (blocadren) (35 trials)
tizanidine (zanaflex) (1 trial)
topiramate (topamax) (2 trials)
travoprost (travatan) (6 trials)
triamcinolone (kenalog) (7 trials)
Key: SmithKline Beckman (0) Acquired (34)
budesonide (rhinocort) (6 trials)
cariprazine (vraylar) (12 trials)
dihydroergotamine (D.H.E. 45) (5 trials)
escitalopram (lexapro) (1 trial)
Key: SmithKline Beckman (0) Acquired (30)
albuterol (proventil) (2 trials)
altretamine (hexalen) (3 trials)
beclomethasone (vanceril) (1 trial)
ceftazidime (fortaz) (3 trials)
Key: SmithKline Beckman (0) Acquired (4)